Manavseva Diagnostic Centre And Pathology Lab Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-11-2024
- Paid Up Capital ₹ 0.10 M
as on 17-11-2024
- Company Age 2 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
About Manavseva Diagnostic Centre And Pathology Lab
The Corporate was formerly known as Manavseva Pathology Laboratory Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Priya Pawar and Avinash Pawar serve as directors at the Company.
- CIN/LLPIN
U85100MH2022PTC377835
- Company No.
377835
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Mar 2022
- Date of AGM
17 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Manavseva Diagnostic Centre And Pathology Lab?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Avinash Pawar  | Director | 03-Mar-2022 | Current |
| Priya Pawar | Director | 03-Mar-2022 | Current |
Financial Performance of Manavseva Diagnostic Centre And Pathology Lab.
Manavseva Diagnostic Centre And Pathology Lab Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Manavseva Diagnostic Centre And Pathology Lab?
Unlock access to Manavseva Diagnostic Centre And Pathology Lab's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Manav Seva Diagnostic Centre (Opc) Private LimitedActive 2 years 10 months
Avinash Pawar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Manavseva Diagnostic Centre And Pathology Lab?
Manavseva Diagnostic Centre And Pathology Lab has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Manavseva Diagnostic Centre And Pathology Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Manavseva Diagnostic Centre And Pathology Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
